BACKGROUND: To describe the use of pumpless extracorporeal interventional lung assist (iLA) for transportation of patients with severe life-threatening acute lung failure from tertiary hospitals to a specialized centre. METHODS: Retrospective analysis in eight patients with severe lung failure requiring interhospital transport, in whom implementation of an iLA system at a tertiary hospital for air/ground transportation was performed. RESULTS: After implementation of iLA, a rapid increase in CO2-elimination (Pa(CO2) before iLA: 8.92+/-2.9 kPa, immediately after implementation: 5.06+/-0.93 kPa, 24 h after implementation: 4.53+/-1.20 kPa [mean+/-SD], P<0.05) was observed and a significant improvement in oxygenation (Pa(O2) before iLA: 6.66+/-2.26 kPa, immediately after implementation: 10.39+/-3.33 kPa, 24 h after implementation: 10.25+/-5.46 kPa, P<0.05) was noted. During transport, no severe complications occurred. Four patients died during further treatment due to multiple trauma or multiple organ failure. CONCLUSIONS: Due to ease of handling, high effectiveness and relatively low costs, iLA seems to be a useful system for treatment and transportation of patients with severe acute lung injury or ARDS suffering from life-threatening hypoxia and/or hypercapnia.
BACKGROUND: To describe the use of pumpless extracorporeal interventional lung assist (iLA) for transportation of patients with severe life-threatening acute lung failure from tertiary hospitals to a specialized centre. METHODS: Retrospective analysis in eight patients with severe lung failure requiring interhospital transport, in whom implementation of an iLA system at a tertiary hospital for air/ground transportation was performed. RESULTS: After implementation of iLA, a rapid increase in CO2-elimination (Pa(CO2) before iLA: 8.92+/-2.9 kPa, immediately after implementation: 5.06+/-0.93 kPa, 24 h after implementation: 4.53+/-1.20 kPa [mean+/-SD], P<0.05) was observed and a significant improvement in oxygenation (Pa(O2) before iLA: 6.66+/-2.26 kPa, immediately after implementation: 10.39+/-3.33 kPa, 24 h after implementation: 10.25+/-5.46 kPa, P<0.05) was noted. During transport, no severe complications occurred. Four patients died during further treatment due to multiple trauma or multiple organ failure. CONCLUSIONS: Due to ease of handling, high effectiveness and relatively low costs, iLA seems to be a useful system for treatment and transportation of patients with severe acute lung injury or ARDS suffering from life-threatening hypoxia and/or hypercapnia.
Authors: Harpreet Matharoo; Mohammadhossein Dabaghi; Niels Rochow; Gerhard Fusch; Neda Saraei; Mohammed Tauhiduzzaman; Stephen Veldhuis; John Brash; Christoph Fusch; P Ravi Selvaganapathy Journal: Biomicrofluidics Date: 2018-01-11 Impact factor: 2.800
Authors: Assad Haneya; Alois Philipp; Maik Foltan; Thomas Mueller; Daniele Camboni; Leopold Rupprecht; Thomas Puehler; Stephan Hirt; Michael Hilker; Reinhard Kobuch; Christof Schmid; Matthias Arlt Journal: Ann Saudi Med Date: 2009 Mar-Apr Impact factor: 1.526
Authors: Markus Zimmermann; Thomas Bein; Matthias Arlt; Alois Philipp; Leopold Rupprecht; Thomas Mueller; Matthias Lubnow; Bernhard M Graf; Hans J Schlitt Journal: Crit Care Date: 2009-01-30 Impact factor: 9.097
Authors: Don Hayes; Joseph D Tobias; Jasleen Kukreja; Thomas J Preston; Andrew R Yates; Stephen Kirkby; Bryan A Whitson Journal: Ann Thorac Med Date: 2013-07 Impact factor: 2.219